LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease

The Lancet Neurology

Volumn 7, Issue 7, 2008, Pages 562-564

  Elbaz, Alexis ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ETHNIC GROUP; GENETIC DISORDER; HUMAN; JEW; LETTER; MUTATION RATE; NORTH AFRICA; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; TUNISIA;

GLYCINE; HUMANS; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; SERINE;

EID: 50249165832     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(08)70118-2     Document Type: Letter

References (9)

1. Healy D., Falchi M., O'Sullivan S., et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case control study. Lancet Neurol 7 (2008) 583-5890
2. Hulihan M., Ishihara-Paul L., Kachergus J., et al. LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic screen. Lancet Neurol 7 (2008) 591-5994
3. Williams-Gray C., Goris A., Foltynie T., et al. Prevalence of the LRRK2 G2019S mutation in a UK community-based idiopathic Parkinson's disease cohort. J Neurol Neurosurg Psychiatry 77 (2006) 665-6667
4. Clark L., Wang Y., Karlins E., et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology 67 (2006) 1786-17891
5. Ozelius L., Senthil G., Saunders-Pullman R., et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354 (2006) 424-4225
6. Goldwurm S., Zini M., Mariani L., et al. Evaluation of LRRK2 G2019S penetrance: relevance for genetic counselling in Parkinson disease. Neurology 68 (2007) 1141-11443
7. Kachergus J., Mata I., Hulihan M., et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 76 (2005) 672-6780
8. Gail M., Pee D., Benichou J., and Carroll R. Designing studies to estimate the penetrance of an identified autosomal dominant mutation: cohort, case-control, and genotyped-proband designs. Genet Epidemiol 16 (1999) 15-139
9. Haugarvoll K., Rademakers R., Kachergus J., et al. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70 (2008) 1456-14560